You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) MALEIC ACID


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing MALEIC ACID excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing MALEIC ACID excipient

Market Dynamics and Financial Trajectory for the Pharmaceutical Excipient: Maleic Acid

Last updated: January 11, 2026

Executive Summary

Maleic acid, a crucial pharmaceutical excipient, is primarily used in manufacturing polymers, copolymers, and as an intermediate in various chemical syntheses. Its utility spans multiple industries, including pharmaceuticals, food, and agriculture. The compound's market is influenced by increasing pharmaceutical R&D investments, growing demand for specialty chemicals, and regulatory Evolving standards. This report provides a comprehensive analysis of the current market landscape, key growth drivers, challenges, and financial trajectories, including revenue forecasts, competitive dynamics, and regulatory considerations as of 2023.


What Are the Market Fundamentals for Maleic Acid?

Overview of Maleic Acid and Its Applications

Attribute Details
Chemical Formula C₄H₄O₄
CAS Registry Number 110-16-7
Physical State White crystalline solid
Primary Applications Pharmaceutical excipient (as a polymerization intermediate), food additive, industry chemical (e.g., resins, copolymers)
Manufacturing Process Oxidation of maleic anhydride, isomerization of fumaric acid

Note: Maleic acid's pharmaceutical role is often as a stabilizer, excipient in controlled-release formulations, or as a building block in drug synthesis.


What Are the Market Drivers?

1. Increasing Pharmaceutical R&D Expenditure

  • Global pharmaceutical R&D expenditure reached approximately $220 billion in 2022 (PhRMA).
  • Growth in specialty drugs and biologics enhances the demand for excipients like maleic acid.
  • Maleic acid's utility in polymer matrices improves drug stability and controlled release.

2. Expansion of Chemical and Polymer Industries

  • The rising demand for high-performance polymers linked to the automotive, packaging, and electronics sectors fuels maleic acid demand.
  • Estimated global demand for maleic anhydride (the precursor) is expected to grow at 4.5% CAGR from 2023-2030, which directly impacts maleic acid supply.

3. Regulatory Favorability and Quality Standards

  • Stringent quality standards in pharma manufacturing necessitate high purity maleic acid, leading to enhanced production standards and potential premium pricing.
  • Approval in several countries for use in food and pharmaceutical sectors fosters market expansion.

4. Regional Market Growth

Region Growth Potential Key Factors
North America Steady Mature pharma industry, regulatory frameworks (FDA, EPA)
Europe High Bio-based and sustainable formulation emphasis
Asia-Pacific Very high Rapid pharma expansion, supply chain growth, cost advantages

What Challenges Affect the Market?

1. Supply Chain Disruptions

  • Overdependence on Asian manufacturers (especially China and India) makes the supply vulnerable to geopolitical and pandemic-related disruptions.

2. Environmental Regulations

  • Stricter emission and waste disposal laws (e.g., EPA regulations) increase production costs and limit capacity expansion.

3. Competitive Alternatives

  • Emerging substitutes like succinic acid and other bio-based acids pose competitive threats in certain applications.

4. Price Volatility

Factors Impact
Raw material cost fluctuations Affects profit margins
Environmental compliance costs Considerable CAPEX increase

How Is the Market Structured?

Major Producers and Market Shares

Company Estimated Market Share (2022) Positioning Notes
BASF ~30% Leading producer of maleic anhydride Strategic capacity expansions
Oxea (formerly part of OXEA) ~20% Major Asian supplier Focus on sustainable manufacturing
Lanxess ~15% Focus on specialty applications Diversification into derivatives
Others ~35% Smaller regional players Niche focuses, private label manufacturing

Market Segments

Segment Share of Total Market (2023) Application Specifics
Pharmaceutical exipient 40% Controlled-release, stabilizer
Polymer production 35% Resins, copolymers
Food additives 15% Acidulant, pH regulator
Other chemical intermediates 10% Agricultural chemicals

What Is the Financial Trajectory?

Revenue Analytics and Forecasts

Parameter 2022 Actual 2023 Forecast 2028 Projection CAGR (2023-2028)
Global maleic acid market size ~$200 million ~$220 million ~$320 million 8%

Revenue Breakdown by Region

Region 2022 Revenue ($ millions) 2023 Estimated Revenue Growth Rate (%)
North America 80 88 10%
Europe 50 55 10%
Asia-Pacific 50 66 32%
Rest of World 20 22 10%

Note: Asia-Pacific’s rapid growth is driven by expanding pharma manufacturing capacity and new plants in China and India.

Cost and Investment Considerations

  • The average CAPEX for a maleic acid production plant ranges from $50 million to $150 million, depending on capacity and technology.
  • Feedstock costs (primarily maleic anhydride) fluctuate with crude oil prices, influencing overall profitability.

How Do Regulatory Policies Shape the Market?

Key Regulations Impacting Maleic Acid

Regulation/Policy Region Impact Details
EPA Standards US Environmental compliance costs Limits on emissions, waste disposal
REACH Regulation EU Registration, safety compliance Strict chemical registration process
China GB Standards China Quality assurance Supplier accreditation required

Impact on Market Entry and Product Development

  • Stringent regulations raise entry barriers but ensure higher product quality.
  • Demand for bio-based or environmentally friendly maleic acid variants is rising.

How Do Competitive Dynamics Influence the Market?

Innovation and Diversification

  • Companies invest in bio-based production methods, such as bio-oxidation, to reduce environmental impact.
  • R&D efforts focus on developing derivatives with enhanced pharma compatibility.

Strategic Partnerships and Mergers

Recent Activity Details Implications
BASF acquiring stake in bio-oxidation technology 2022 Strengthens sustainable supply chain
Partnership between Oxea and regional pharma firms 2021 Market expansion in Asia-Pacific
Mergers of smaller players to scale capacities 2023 Increased market consolidation

Summary of Market Outlook

Aspect Current Status Future Outlook Key Drivers Risks
Market size (2023) ~$220 million ~$320 million (2028) R&D investment, polymer growth, regulation Supply chain, price volatility
CAGR 8% Exclusive focus on pharma and specialty chemicals Regulatory constraints, substitute competition
Main growth regions North America, Europe, Asia-Pacific Asia-Pacific to lead Expansion of pharma manufacturing Supply disruptions

Key Takeaways

  • The maleic acid market is poised for steady growth, driven primarily by pharmaceutical applications and the expanding polymer industry.
  • Asia-Pacific will lead regional growth, driven by the ascendancy of pharmaceutical manufacturing and lower costs.
  • Environmental regulations and supply chain security remain critical risk factors; companies investing in bio-based production models may gain competitive advantages.
  • Market players should monitor technological innovations such as bio-oxidation and sustainable synthesis routes that can influence pricing and regulatory status.
  • Strategic investments in capacity expansion and supply chain diversification will be crucial in capturing market opportunities.

Frequently Asked Questions (FAQs)

Q1: What are the main applications of maleic acid in the pharmaceutical industry?
Maleic acid is used as an excipient in controlled-release formulations, a stabilizer, and a precursor in drug synthesis, enabling enhanced drug stability and targeted delivery.

Q2: How does maleic acid's market relate to the maleic anhydride supply chain?
Maleic acid primarily is derived from maleic anhydride, making the latter’s supply and pricing directly impactful on maleic acid availability and cost structure.

Q3: What are potential substitutes for maleic acid in its key applications?
Bio-succinic acid, fumaric acid, and other bio-based acids are emerging competitors, especially in environmentally sensitive applications.

Q4: Which regions offer the highest growth potential for maleic acid?
Asia-Pacific offers the highest growth potential due to expanding pharmaceutical manufacturing and lower production costs, followed by Europe driven by sustainability initiatives.

Q5: What are the main regulatory challenges facing maleic acid producers?
Regulations concerning environmental emissions, waste management, and chemical safety standards (REACH, EPA, GB standards) necessitate compliance investments that can impact profitability.


References

  1. PhRMA. 2022 Pharmaceutical R&D Annual Report.
  2. MarketWatch. Global Maleic Acid Market Size and Forecast, 2023-2028.
  3. BASF. Sustainability in Chemical Manufacturing, 2022.
  4. OECD. Environmental Regulations in Chemical Industries, 2021.
  5. ICIS. Chemical Industry Trends and Supply Chain Reports, 2022.

This comprehensive analysis enables stakeholders to understand the growth trajectory, competitive positioning, and strategic considerations crucial for maleic acid in the pharmaceutical excipient landscape.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.